Precision Medicine Approaches to Cancer Diagnosis and Treatment: Focus on Cancer Stem Cell Biomarkers

Q3 Medicine

Open Biomarkers Journal Pub Date : 2018-02-08 DOI:10.2174/1875318301808010009

K. Rygiel

引用次数: 0

Abstract

Recent research evidence has revealed that cancer cells contain a subpopulation of cancer stem cells (CSCs) that can remain even after traditional oncology therapies (e.g.: surgical resection of a tumor, radiation therapy (RT), and chemotherapy (ChT)), and can subsequently regenerate the original tumor or metastases, which are resistant to standard anticancer treatments. Such a resistance can be activated in various CSC populations, via different signal transduction pathways.

查看原文本刊更多论文

癌症诊断和治疗的精准医学方法:聚焦于癌症干细胞生物标志物

最近的研究证据表明，癌细胞含有一种癌症干细胞(CSCs)亚群，即使在传统的肿瘤治疗(如手术切除肿瘤、放射治疗(RT)和化疗(ChT))之后，它们也能存活下来，并随后再生原始肿瘤或转移灶，这对标准的抗癌治疗具有耐药性。这种抗性可以在不同的CSC群体中通过不同的信号转导途径被激活。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Open Biomarkers Journal Medicine-Medicine (miscellaneous)

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： The Open Biomarkers Journal is an Open Access online journal, which publishes original full-length, short research articles and reviews on biomarkers in clinical, medical and pharmaceutical research. The coverage includes biomarkers of disease, new biomarkers, exposure to drugs, genetic effects, and applications of biomarkers. The Open Biomarkers Journal, a peer reviewed journal, aims to provide the most complete and reliable source of information on current developments in the field. The emphasis will be on publishing quality articles rapidly and freely available to researchers worldwide.